Shuetsu Fukushi

National Institute of Infectious Diseases

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates”.

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.26.505450

N/A

1.0DataRank · unranked

8 citations

Shun Iida, Peter Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki‐Horimoto +25 more

Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis

Scientific Reports(2021)10.1038/s41598-021-81752-0

N/A

0.489DataRank · unranked

25 citations

Hiroko Miyamoto, Takeshi Saito, Reiko Yoshida, Rashid Manzoor, Masahiro Kajihara +12 more

Characterization of a new SARS-CoV-2 variant that emerged in Brazil

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106535118

N/A

0DataRank · unranked

87 citations

Peter Halfmann, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, S. Chiba, Tokiko Watanabe +54 more

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

New England Journal of Medicine(2022)10.1056/nejmc2207519

N/A

0DataRank · unranked

323 citations

Seiya Yamayoshi, Viviana Simon, Harm van Bakel, Emilia Mia Sordillo, Andrew Pekosz +11 more

Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

Nature(2022)10.1038/s41586-022-05482-7

N/A

0DataRank · unranked

110 citations

Peter Halfmann, Shun Iida, Seiya Yamayoshi, Yuri Furusawa, Maki Kiso +21 more